Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by KBC Group NV
KBC Group NV boosted its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 72.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,336 shares of the specialty pharmaceutical company’s stock after purchasing an additional 982 shares during […]
KBC Group NV boosted its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 72.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,336 shares of the specialty pharmaceutical company’s stock after purchasing an additional 982 shares during […]
